ProfileGDS5678 / 1416959_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 56% 57% 56% 60% 48% 58% 59% 56% 58% 57% 56% 51% 56% 56% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4446156
GSM967853U87-EV human glioblastoma xenograft - Control 23.4342657
GSM967854U87-EV human glioblastoma xenograft - Control 33.4270856
GSM967855U87-EV human glioblastoma xenograft - Control 43.5267360
GSM967856U87-EV human glioblastoma xenograft - Control 53.1000448
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5826358
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.621459
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4115856
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.5067658
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4331257
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4190556
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1897951
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.442256
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4243456